Sunnyvale, CA, United States
Sunnyvale, CA, United States

Time filter

Source Type

Global Surgical Robots Market Forecast to 2024 – New report by Data Bridge Market Research Global Surgical Robots Market, by Product (Robotic Systems, Instruments and Accessories, Service), by Brands (Da Vinci Surgical System, Cyberknife, Renaissance, Flex, Artas, Rosa and Others), by Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy and Others), by Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024. Dallas, TX, February 16, 2017 --( The global surgical robots market is segmented on the basis of product, brands, application and by geography. On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service. On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others. Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others. Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 16, 2017 --( PR.com )-- Global Surgical Robots market is expected to reach USD 14.5 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 13.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global surgical robots market is segmented on the basis of product, brands, application and by geography.On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service.On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others.Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others.Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


News Article | March 2, 2017
Site: www.prnewswire.co.uk

The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching http://www.cyberknife.com and http://www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential treatment options. Enhanced functionality and ease-of-use puts the information patients need at their fingertips. "Patients have told us they want concise information on potential treatment options that is easy to understand, and they want to hear from others who can share their real-world experiences," said Susan Hopkins, Chief Marketing Officer at Accuray. "We're committed to providing cancer patients with educational tools and resources which will enable them, in conversation with their physicians, to make the treatment decisions that are right for them. We are launching these new patient websites along with a major update to our Accuray.com website as well." The CyberKnife®, TomoTherapy® and Radixact™ Systems enable physicians to deliver precise, non-invasive radiation treatment options while minimizing side effects, helping to improve quality of life. The product websites feature a variety of resources, including: "Following successful treatment with the CyberKnife System for a tumor on my spine, I gained a new perspective on life. I want to help other people who, like me, are given a frightening diagnosis. In addition to volunteering, I decided to share my story on http://www.cyberknife.com," said Maria H. "The new website has the information I would want as a patient considering treatment, and is really easy to navigate. I feel good about sending people to the site and hope my story inspires others who find themselves in a similar situation." By 2030, the global cancer incidence rate is projected to reach 25 million[i]. Radiotherapy (RT) is a fundamental component of oncology care[ii] and an estimated 50% of cancer patients would benefit from radiotherapy for treatment of localized disease, local control, and palliation.[iii] "When my doctor diagnosed me with multiple myeloma I remember saying to myself, 'I refuse to die. I want to learn as much as I can about my condition.' Coming to grips with cancer is difficult but can be easier when advanced treatment options are identified. The Internet is an important resource for information that can help patients make a decision," said Carol R. "I recommend visiting the new tomotherapy.com website. It's filled with information a potential patient might need to help them, in discussion with their doctor, to decide if it's the right treatment for them. The patient stories, mine included, provide a real-world perspective on what to expect from a TomoTherapy® treatment." The Radixact™ Treatment Delivery System is the next generation TomoTherapy platform, designed to enable doctors to more efficiently and effectively deliver precise radiation treatments to more patients. The system offers doctors the opportunity to improve the cancer treatment experience throughout a patient's treatment journey, including when retreatment is necessary. About the CyberKnife®, TomoTherapy and Radixact™ Systems The Accuray CyberKnife M6™ Series, TomoTherapy H™ Series and Radixact treatment solutions cover the entire spectrum of radiation therapy needs. The CyberKnife M6 Series enables precise, high-quality, dose distributions to be confidently delivered to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The CyberKnife System is the only robotic full-body radiosurgery system available today. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its innovative design enables treatment plans to be delivered with integrated, daily CT image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures. The Radixact System empowers clinicians by integrating treatment planning, data management and treatment delivery. Using low-dose fan beam megavoltage x-ray radiation, refined beamline and fast imaging technology, the system delivers scalable and highly reliable treatment for patients with a variety of treatment requirements. Further information on Accuray and the CyberKnife, TomoTherapy and Radixact Systems is available at http://www.accuray.com For Important Safety Information please refer to Accuray website. Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit http://www.accuray.com. Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to clinical applications, clinical results, patient outcomes and Accuray's leadership position in radiation oncology innovation and technologies. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations, including but not limited to the risks detailed from time to time under the heading "Risk Factors" in the company's report on Form 10-K, filed on August 24, 2016, the company's reports on Form 10-Q, filed on November 1, 2016 and February 3, 2017, and as updated periodically with the company's other filings with the SEC. Forward-looking statements speak only as of the date the statements are made and are based on information available to Accuray at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements. [i.] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. [iii.] Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014; 112: 140-44.


News Article | February 21, 2017
Site: www.prnewswire.com

SUNNYVALE, Calif., Feb. 21, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that the Company will present at Cowen and Company's 37th Annual Healthcare Conference in Boston on Monday, March 6, 2017. Accuray's fireside chat with analyst Joshua Jennings, M.D....


Patent
Accuray | Date: 2011-06-08

Systems, methods, and related computer program products for medical imaging and image-guided radiation treatment (IGRT) are described. In one preferred embodiment, an IGRT system provides intrafraction target tracking based on a comparison of intrafraction x-ray tomosynthesis image data with initial x-ray tomosynthesis image data acquired with the patient in an initial treatment position, the initial x-ray tomosynthesis image data having an inherent registration with co-acquired image data from a setup imaging system integral with, or having known geometry relative to, the tomosynthesis imaging system. Repeated registration of intrafraction x-ray tomosynthesis image data with pre-acquired reference image data from a different frame of reference is not required during intrafraction radiation delivery. Advantages include streamlined intrafraction computation and/or reduced treatment delivery margins.


Patent
Accuray | Date: 2011-06-08

Systems, methods, and related computer program products for medical imaging and image-guided radiation treatment (IGRT) are described. In one embodiment, an IGRT system selectively integrates x-ray source arrays, dual-energy imaging, stereoscopic imaging, static and dynamic source collimation, and/or inverse geometry tomosynthesis imaging to acquire and/or track a target during radiation treatment. Advantages include reduced patient x-ray dose and/or reduced treatment delivery margins.


Patent
Accuray | Date: 2011-07-14

An image registration process for detecting a change in position of a surgical target, such as a tumor, within a patient is disclosed. A pre-operative model of the target and surrounding area is generated, then registered to live patient images to determine or confirm a location of the target during the course of surgery. Image registration is based on a non-iterative image processing logic that compares a similarity measure for a template of the target (generated from the pre-operative model) at one location within the live image to other locations within the live image.


The disclosure relates to systems and methods for interleaving operation of a linear accelerator that use a magnetron as the source of electromagnetic waves for use in accelerating electrons to at least two different ranges of energies. The accelerated electrons can be used to generate x-rays of at least two different energy ranges. In certain embodiments, the accelerated electrons can be used to generate x-rays of at least two different energy ranges. The systems and methods are applicable to traveling wave linear accelerators.


The disclosure relates to systems and methods for interleaving operation of a standing wave linear accelerator (LINAC) for use in providing electrons of at least two different energy ranges, which can be contacted with x-ray targets to generate x-rays of at least two different energy ranges. The LINAC can be operated to output electrons at different energies by varying the power of the electromagnetic wave input to the LINAC, or by using a detunable side cavity which includes an activatable window.


Provided herein are systems and methods for operating a traveling wave linear accelerator to generate stable electron beams at two or more different intensities by varying the number of electrons injected into the accelerator structure during each pulse by varying the width of the beam pulse, i.e., pulse width.


Systems, methods, and related computer program products for image-guided radiation treatment (IGRT) are described. For one preferred embodiment, an IGRT apparatus is provided comprising a gantry frame including a ring member, the ring member being rotatable around a substantially horizontal, longitudinally extending central axis, the ring member having first and second horizontally opposing ends. The IGRT apparatus further comprises a radiation treatment head coupled to the ring member by an arm member, the arm member being connected to the ring member at an arm member base. Preferably, the IGRT apparatus is further characterized in that the arm member extends outwardly from the first end of the ring member in a direction away from the second end and is supported only by the arm member base, and the radiation treatment head is dynamically movable in at least a longitudinal direction toward and away from the first end of the ring member.

Loading Accuray collaborators
Loading Accuray collaborators